Seven & i Holdings Co., Ltd.
Consolidated Results and Store Information for FY2025–FY2026 (First Quarter FY2026) | Seven & i Holdings
Highlights of the FY2025 consolidated results and cumulative results for FY2026 Q1, along with full-year guidance. Sales, operating income, and EBITDA for domestic and international CVS segments, segment-by-segment information, capital expenditure, depreciation, and interest-bearing debt are presented, with updates on ratings from agencies such as S&P. Also explains the partial non-consolidation of Seven Bank and the impact of SEGMENT changes.
Key Figures
- Sales: Full year 10,430,269 million yen / FY2025 total
- EBITDA: 942,893 million yen / FY2025 total
- Net income attributable to owners of parent: 292,760 million yen / FY2025 cumulative
- Total assets: 9,565,703 million yen / as of May 2026
- Total liabilities: 5,849,039 million yen / as of May 2026
AI要約
Key points of the earnings
Disclosure of consolidated results for FY2025 and cumulative results for FY2026 Q1. Domestic and overseas CVS segment sales show a stable trend, with a high overseas composition. The Seven Bank and SST business group was included in the consolidation in the first half of FY2025, and from the second half of FY2025 onward are consolidated as equity-method affiliates. The full-year forecast for FY2026 remains set, with discussion of segment-level investment activity and depreciation trends.
Key points on shareholder returns and financial position
Interest-bearing debt totals about ¥2.27 trillion, with a breakdown into long-term and short-term components, and ratings are disclosed by various agencies such as S&P. The full-year forecast notes currency exchange and borrowing condition risks, and the stance is to maintain financial health while continuing growth investments.
Revenue Trend
Operating Income Trend
Segment Revenue Composition
EBITDA Margin by Segment
Full Year Forecast vs Actual
Seven & I Holdings
Company overview · Stock price · Financial data · All IR
